CIAM
BNGO icon

Caitong International Asset Management’s Bionano Genomics BNGO Stock Holding History

Caitong International Asset Management’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6 Buy
+5
New +$6 ﹤0.01% 2700

Other funds holding BNGO

GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CWP
Concord Wealth Partners Abingdon, Virginia $873M AUM 24.02% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Caitong International Asset Management's BNGO Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in Bionano Genomics (BNGO) in Q2 2026: 5 shares worth $6. The stake represents ﹤0.01% of the portfolio and ranks #2700 among its holdings.

9 funds tracked by Wall St. Rank hold BNGO as of Q2 2026.

  • Caitong International Asset Management held 5 shares of Bionano Genomics worth $6 as of Q2 2026.
  • Bionano Genomics was a new Caitong International Asset Management position in Q2 2026.
  • Bionano Genomics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #2700 holding.
  • 9 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.